Sector ratings DexCom, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-29 EDT			5-day change	1st Jan Change
86.64 ^USD	-0.05%		-3.23%	+30.54%

09-28	Dexcom Publishes New Report During Easd 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care	CI
09-28	Tandem Diabetes Expands Insulin Delivery System to 12 New Countries	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
DEXCOM, INC.	32.69B	BBB
ABBOTT LABORATORIES	175B	BBB
MEDTRONIC PLC	111B	BBB
CENCORA, INC.	58.7B	AA
HOYA CORPORATION	49.27B	AAA
BECTON, DICKINSON AND COMPANY	49.57B	A
MEDLINE INC.	30.69B	A
WEST PHARMACEUTICAL SERVICES, INC.	26.51B	AAA
SARTORIUS STEDIM BIOTECH	23.95B	BBB
TERUMO CORPORATION	21.31B	AA
STERIS PLC	20.54B	AAA	-
ZIMMER BIOMET HOLDINGS, INC.	17.42B	A
SOLVENTUM CORPORATION	15.2B	BBB
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	15.06B	A
BAXTER INTERNATIONAL INC.	12.14B	A
REPLIGEN CORPORATION	10.98B	AA
AVANTOR, INC.	10.31B	AA
DEMANT A/S	10.06B	AA
ALIGN TECHNOLOGY, INC.	10.23B	A
GLOBUS MEDICAL, INC.	10.16B	CCC
Average	35.54B	AA
Weighted average by Cap.		AA